• 1. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Research Brief on 3-Bromo-2-(2-methoxyethoxy)pyridine (CAS: 760207-91-8) in Chemical Biology and Pharmaceutical Applications

3-Bromo-2-(2-methoxyethoxy)pyridine (CAS: 760207-91-8) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, particularly in the development of kinase inhibitors and other small-molecule therapeutics. Recent studies have highlighted its role in modulating protein-protein interactions and its potential as a scaffold for drug discovery.

One of the most notable applications of 3-Bromo-2-(2-methoxyethoxy)pyridine is its use in the synthesis of Bruton's tyrosine kinase (BTK) inhibitors. BTK is a critical target in the treatment of B-cell malignancies and autoimmune diseases. Researchers have demonstrated that derivatives of this compound exhibit high selectivity and potency against BTK, making them promising candidates for clinical development. The methoxyethoxy side chain is particularly important for enhancing solubility and bioavailability, addressing a common challenge in drug design.

In addition to its role in BTK inhibition, 3-Bromo-2-(2-methoxyethoxy)pyridine has been explored as a building block for the development of fluorescent probes and imaging agents. Its bromine moiety allows for facile functionalization via cross-coupling reactions, enabling the attachment of various fluorophores or targeting groups. This versatility has been leveraged in studies aimed at visualizing cellular processes and tracking drug distribution in vivo.

Recent advancements in synthetic methodologies have further expanded the utility of this compound. For instance, palladium-catalyzed cross-coupling reactions have been optimized to achieve high yields and regioselectivity, facilitating the rapid assembly of complex molecular architectures. These synthetic innovations have accelerated the discovery of novel analogs with improved pharmacological properties.

Despite its promising applications, challenges remain in the large-scale production and purification of 3-Bromo-2-(2-methoxyethoxy)pyridine. Researchers are actively investigating greener and more efficient synthetic routes to address these issues. Additionally, ongoing studies are focused on elucidating the compound's mechanism of action and optimizing its pharmacokinetic profile to enhance therapeutic efficacy.

In conclusion, 3-Bromo-2-(2-methoxyethoxy)pyridine (CAS: 760207-91-8) represents a valuable tool in chemical biology and drug discovery. Its unique structural features and functional versatility make it a cornerstone in the development of next-generation therapeutics. Continued research in this area is expected to yield novel insights and applications, further solidifying its importance in the field.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)